How is combination therapy with ACEI and ARB applied in patients with acute myocardial infarction?
Yamamoto
Kazuhiro
K
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D004359:Drug Therapy, Combination; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride